ADR Term |
ADReCS ID |
ADR Frequency (FAERS)
|
ADR Severity Grade (FAERS)
|
ADR Severity Grade (CTCAE)
|
Renal impairment | 20.01.03.010 | - | - | Not Available |
Respiratory tract infection | 11.01.08.017; 22.07.07.001 | 0.000533% | | Not Available |
Bone marrow failure | 01.03.03.005 | 0.002131% | | |
Acute graft versus host disease | 12.02.09.002; 10.02.01.028 | 0.001668% | | Not Available |
Chronic graft versus host disease | 12.02.09.003; 10.02.01.029 | 0.000347% | | Not Available |
Cytopenia | 01.03.03.012 | 0.000533% | | Not Available |
Haematological malignancy | 16.21.01.002; 01.13.01.003 | 0.001251% | | Not Available |
Treatment failure | 08.06.01.017 | 0.000139% | | Not Available |
Brain injury | 19.07.03.007; 17.11.01.003 | 0.000208% | | Not Available |
X-linked lymphoproliferative syndrome | 16.21.02.003; 11.05.10.005; 10.03.01.003; 03.17.01.002; 01.13.02.003 | - | - | Not Available |
Acute kidney injury | 20.01.03.016 | 0.003197% | | |
Posterior reversible encephalopathy syndrome | 17.13.02.007 | 0.005861% | | |
Pneumocystis jirovecii pneumonia | 22.07.08.009; 11.03.07.005 | 0.000278% | | Not Available |
Autoimmune haemolytic anaemia | 10.04.01.005; 01.06.01.004 | 0.000799% | | Not Available |
Immune thrombocytopenic purpura | 01.08.01.007; 10.04.01.008 | 0.000347% | | Not Available |
Multiple organ dysfunction syndrome | 08.01.03.057 | 0.000973% | | |
B precursor type acute leukaemia | 16.01.01.004; 01.10.01.004 | 0.000139% | | Not Available |
Richter's syndrome | 16.28.02.005; 01.15.02.005 | 0.000347% | | Not Available |
Metastatic squamous cell carcinoma | 16.16.01.010 | 0.000139% | | Not Available |
Graft versus host disease in skin | 12.02.09.031; 10.02.01.062; 23.07.04.025 | 0.000533% | | Not Available |
Graft versus host disease in liver | 12.02.09.029; 10.02.01.060; 09.01.07.033 | 0.000533% | | Not Available |
Clonal evolution | 16.32.03.022 | 0.000533% | | Not Available |
Acute graft versus host disease in skin | 23.07.04.020; 12.02.09.022; 10.02.01.053 | 0.000799% | | Not Available |
Invasive lobular breast carcinoma | 16.10.01.014; 21.05.01.022 | 0.000533% | | Not Available |
Graft versus host disease in gastrointestinal tract | 10.02.01.059; 12.02.09.028; 07.11.01.027 | 0.000278% | | Not Available |
Toxic leukoencephalopathy | 17.13.02.012; 12.03.01.059 | 0.000347% | | Not Available |